Ting Ding

702 total citations
31 papers, 544 citations indexed

About

Ting Ding is a scholar working on Molecular Biology, Oncology and Civil and Structural Engineering. According to data from OpenAlex, Ting Ding has authored 31 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Civil and Structural Engineering. Recurrent topics in Ting Ding's work include Fibroblast Growth Factor Research (2 papers), Pharmacological Effects of Natural Compounds (2 papers) and Structural Engineering and Vibration Analysis (2 papers). Ting Ding is often cited by papers focused on Fibroblast Growth Factor Research (2 papers), Pharmacological Effects of Natural Compounds (2 papers) and Structural Engineering and Vibration Analysis (2 papers). Ting Ding collaborates with scholars based in China. Ting Ding's co-authors include Ling Xiao, Qianyu Liu, Hongbo Xin, Quanwen Liu, Wenjie Zhang, Jingyuan Li, Ke‐Yu Deng, Xianghong Lu, Xiaokun Li and Yan Huang and has published in prestigious journals such as Oncogene, Scientific Reports and ACS Applied Materials & Interfaces.

In The Last Decade

Ting Ding

29 papers receiving 542 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ting Ding China 12 198 95 87 76 64 31 544
Zhi-Jie Liang China 12 236 1.2× 119 1.3× 67 0.8× 92 1.2× 50 0.8× 25 577
Rossana Rossi Italy 16 360 1.8× 136 1.4× 117 1.3× 107 1.4× 44 0.7× 33 890
A.C. Mamede Portugal 12 197 1.0× 99 1.0× 65 0.7× 217 2.9× 55 0.9× 20 806
Tao Tan China 13 232 1.2× 32 0.3× 176 2.0× 74 1.0× 21 0.3× 37 645
Sarath Meduru United States 11 140 0.7× 50 0.5× 35 0.4× 70 0.9× 11 0.2× 15 351
Kyu-Sil Choi South Korea 11 383 1.9× 34 0.4× 83 1.0× 58 0.8× 17 0.3× 13 786
Sheik Wisel United States 15 243 1.2× 132 1.4× 73 0.8× 254 3.3× 9 0.1× 25 638
Chao Rong China 15 241 1.2× 24 0.3× 108 1.2× 53 0.7× 12 0.2× 36 600

Countries citing papers authored by Ting Ding

Since Specialization
Citations

This map shows the geographic impact of Ting Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ting Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ting Ding more than expected).

Fields of papers citing papers by Ting Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ting Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ting Ding. The network helps show where Ting Ding may publish in the future.

Co-authorship network of co-authors of Ting Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Ting Ding. A scholar is included among the top collaborators of Ting Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ting Ding. Ting Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ding, Ting, et al.. (2025). Finite element analysis of the seismic performance of wind and rain bridge. Scientific Reports. 15(1). 26316–26316.
3.
Ding, Ting, et al.. (2025). IL-17A regulates airway remodelling in COPD through the PI3K/AKT/mTOR pathway. Scientific Reports. 15(1). 16546–16546. 2 indexed citations
4.
Ma, Yan, Xiaohua Chen, Ting Ding, et al.. (2023). KAT7 promotes radioresistance through upregulating PI3K/AKT signaling in breast cancer. Journal of Radiation Research. 64(2). 448–456. 10 indexed citations
5.
Ding, Ting, et al.. (2023). BnPLP1 Positively Regulates Flowering Time, Plant Height, and Main Inflorescence Length in Brassica napus. Genes. 14(12). 2206–2206. 3 indexed citations
6.
Li, Yuanhong, Lei Cai, Ting Ding, et al.. (2023). Quantitative Trait Locus Mapping Combined with RNA Sequencing Reveals Candidate Genes for Chlorophyll Content in Oilseed Rape Leaves. Journal of Plant Growth Regulation. 43(4). 1260–1271.
7.
Ma, Yan, Haibo Zhang, Cheng Chen, et al.. (2022). TRIM32 promotes radioresistance by disrupting TC45-STAT3 interaction in triple-negative breast cancer. Oncogene. 41(11). 1589–1599. 14 indexed citations
8.
Wang, Xiao, Yanwei Lu, H. Henry Guo, et al.. (2021). Stereotactic Body Radiotherapy and Conventional Radiotherapy Induce Cytoskeleton Extension and Enlargement of Cell Morphology in Non-Small Cell Lung Cancer. Dose-Response. 19(4). 1485814451–1485814451. 3 indexed citations
9.
10.
Wang, Huafu, et al.. (2018). Liuwei Dihuang exhibits antidiabetic effects through inhibiting α-amylase and α-glucosidase. médecine/sciences. 34. 4–7. 5 indexed citations
11.
Liu, Quanwen, Qianyu Liu, Jingyuan Li, et al.. (2018). Therapeutic efficiency of human amniotic epithelial stem cell-derived functional hepatocyte-like cells in mice with acute hepatic failure. Stem Cell Research & Therapy. 9(1). 321–321. 37 indexed citations
12.
13.
14.
Ding, Ting, Lan Chen, Lihai Zhai, Yan Fu, & Bai‐Wang Sun. (2017). Compatibility study of rivaroxaban and its pharmaceutical excipients. Journal of Thermal Analysis and Calorimetry. 130(3). 1569–1573. 19 indexed citations
15.
Wu, Jianzhang, Tao Wei, Qinqin Tang, et al.. (2015). Discovery and anti-cancer evaluation of two novel non-ATP-competitive FGFR1 inhibitors in non-small-cell lung cancer. BMC Cancer. 15(1). 276–276. 14 indexed citations
16.
Zhou, Yunfang, Shuanghu Wang, Ting Ding, et al.. (2015). Pharmacokinetic interaction study of combining imatinib with dasatinib in rats by UPLC–MS/MS. Drug Development and Industrial Pharmacy. 41(12). 1948–1953. 5 indexed citations
17.
Feng, Jianpeng, Bing Xiao, Wenbo Chen, et al.. (2015). Synthesis and Anti‐Inflammatory Evaluation of Novel C66 Analogs for the Treatment of LPS‐Induced Acute Lung Injury. Chemical Biology & Drug Design. 86(4). 753–763. 11 indexed citations
18.
Zhou, Yunfang, Shuanghu Wang, Ting Ding, et al.. (2014). Evaluation of the effect of apatinib (YN968D1) on cytochrome P450 enzymes with cocktail probe drugs in rats by UPLC–MS/MS. Journal of Chromatography B. 973. 68–75. 29 indexed citations
19.
Liang, Guang, Gaozhi Chen, Lili Jiang, et al.. (2014). Synthesis and biological evaluation of novel indole-2-one and 7-aza-2-oxindole derivatives as anti-inflammatory agents. Drug Design Development and Therapy. 8. 1869–1869. 12 indexed citations
20.
Huang, Jian, Ting Ding, Min Yang, et al.. (2011). Antitumor activity and drug interactions of proteasome inhibitor Bortezomib in human high-risk myelodysplastic syndrome cells. International Journal of Hematology. 93(4). 482–493. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhi-Jie Liang Breakdown of academic impact, for papers by Rossana Rossi Breakdown of academic impact, for papers by A.C. Mamede Breakdown of academic impact, for papers by Tao Tan Breakdown of academic impact, for papers by Sarath Meduru Breakdown of academic impact, for papers by Kyu-Sil Choi Breakdown of academic impact, for papers by Sheik Wisel Breakdown of academic impact, for papers by Chao Rong
Rankless by CCL
2026